TY - JOUR
T1 - Comparison of 1-Month and 12-Month Vessel Responses Between the Polymer-Free Biolimus A9-Coated Stent and the Durable Polymer Everolimus-Eluting Stent
AU - Ishihara, Takayuki
AU - Mizote, Isamu
AU - Nakamura, Daisuke
AU - Okamoto, Naotaka
AU - Shiraki, Tatsuya
AU - Itaya, Naoki
AU - Tsujimura, Takuya
AU - Takahara, Mitsuyoshi
AU - Nakayoshi, Takaharu
AU - Iida, Osamu
AU - Hata, Yosuke
AU - Nishino, Masami
AU - Ueno, Takafumi
AU - Nakatani, Daisaku
AU - Hikoso, Shungo
AU - Nanto, Shinsuke
AU - Mano, Toshiaki
AU - Sakata, Yasushi
N1 - Publisher Copyright:
© 2022 Japanese Circulation Society. All rights reserved.
PY - 2022
Y1 - 2022
N2 - Background: A polymer-free biolimus A9-coated stent (PF-BCS) may achieve better arterial healing than a durable polymer drugeluting stent owing to its polymer-free feature. Methods and Results: This multicenter, prospective, observational study enrolled 105 patients (132 lesions) who underwent PFBCS (51 patients, 71 lesions) or durable polymer everolimus-eluting stent (DP-EES, 54 patients, 61 lesions) implantation. Serial coronary angioscopy (CAS) and optical coherence tomography (OCT) examinations were performed at 1 and 12 months, and the serial vessel responses were compared between PF-BCS and DP-EES. The primary outcome measure was the incidence of subclinical intrastent thrombus on CAS. The secondary outcome measures were: adequate strut coverage (≥40 μm) on OCT and maximum yellow color grade on CAS. The incidence of thrombus was high at 1 month (100% vs. 93%, P=0.091), but decreased at 12 months (18% vs. 25%, P=0.56), without a significant difference between PF-BCS and DP-EES. The adequate strut coverage rate was significantly higher (84±14% vs. 69±22%, P<0.001) and yellow color was significantly less intense (P=0.012) at 12 months in PF-BCS than in DP-EES; however, they were not significantly different at 1 month (adequate strut coverage: 47±21% vs. 50±17%, P=0.40; yellow color: P=0.99). Conclusions: Although the thrombogenicity of PF-BCS was similar to that of DP-EES, the adequate coverage and plaque stabilization rates of PF-BCS were superior to those of DP-EES at 12 months.
AB - Background: A polymer-free biolimus A9-coated stent (PF-BCS) may achieve better arterial healing than a durable polymer drugeluting stent owing to its polymer-free feature. Methods and Results: This multicenter, prospective, observational study enrolled 105 patients (132 lesions) who underwent PFBCS (51 patients, 71 lesions) or durable polymer everolimus-eluting stent (DP-EES, 54 patients, 61 lesions) implantation. Serial coronary angioscopy (CAS) and optical coherence tomography (OCT) examinations were performed at 1 and 12 months, and the serial vessel responses were compared between PF-BCS and DP-EES. The primary outcome measure was the incidence of subclinical intrastent thrombus on CAS. The secondary outcome measures were: adequate strut coverage (≥40 μm) on OCT and maximum yellow color grade on CAS. The incidence of thrombus was high at 1 month (100% vs. 93%, P=0.091), but decreased at 12 months (18% vs. 25%, P=0.56), without a significant difference between PF-BCS and DP-EES. The adequate strut coverage rate was significantly higher (84±14% vs. 69±22%, P<0.001) and yellow color was significantly less intense (P=0.012) at 12 months in PF-BCS than in DP-EES; however, they were not significantly different at 1 month (adequate strut coverage: 47±21% vs. 50±17%, P=0.40; yellow color: P=0.99). Conclusions: Although the thrombogenicity of PF-BCS was similar to that of DP-EES, the adequate coverage and plaque stabilization rates of PF-BCS were superior to those of DP-EES at 12 months.
KW - Coronary angioscopy
KW - Durable polymer everolimus-eluting stent
KW - Optical coherence tomography
KW - Polymer-free biolimus A9-coated stent
UR - https://www.scopus.com/pages/publications/85137125090
U2 - 10.1253/circj.CJ-22-0098
DO - 10.1253/circj.CJ-22-0098
M3 - Article
C2 - 35660701
AN - SCOPUS:85137125090
SN - 1346-9843
VL - 86
SP - 1397
EP - 1408
JO - Circulation Journal
JF - Circulation Journal
IS - 9
ER -